Pill Identifier App

Pharmaceutical Sales 2010

The following is a list of the top 200 pharmaceutical drugs by retail sales in 2010, listed by U.S. sales value and brand name.
New: Quarterly Top 100 prescription sales data now available, from Q1 2011 more....

Top 200 Drugs for 2010 by Sales

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Rank Drug Current Manufacturer Total Sales ($000) % Change 2009
1 (1) Nexium AstraZeneca Pharmaceuticals, LP 5,276,153 4.9%
2 (1) Lipitor Pfizer Inc 5,272,576 -2.3%
3 Plavix Bristol-Myers Squibb Company 4,675,483 10.2%
4 Advair Diskus GlaxoSmithKline 3,655,206 -1.0%
5 (3) OxyContin Purdue Pharma LP 3,554,751 13.1%
6 Abilify Bristol-Myers Squibb Company 3,514,265 12.7%
7 Singulair Merck & Co., Inc. 3,324,909 8.9%
8 (3) Seroquel AstraZeneca Pharmaceuticals, LP 3,222,055 2.4%
9 (5) Crestor AstraZeneca Pharmaceuticals, LP 2,922,687 27.0%
10 (1) Cymbalta Eli Lilly and Company 2,638,536 7.6%
11 (2) Actos Takeda Pharmaceuticals U.S.A., Inc 2,631,930 4.2%
12 (1) Lexapro Forest Pharmaceuticals, Inc 2,483,391 4.6%
13 (2) Zyprexa Eli Lilly and Company 2,036,092 7.7%
14 (9) Spiriva Boehringer Ingelheim Pharmaceuticals, Inc 1,593,593 19.3%
15 (3) Lantus Sanofi (formerly Sanofi Aventis) 1,525,697 0.3%
16 (6) Aricept Eisai Corporation 1,522,517 13.3%
17 (2) Lyrica Pfizer Inc 1,478,158 -0.1%
18 (6) Diovan Novartis Corporation 1,443,539 7.0%
19 (7) Effexor XR Pfizer Inc 1,431,042 -40.1%
20 (7) Concerta Johnson & Johnson 1,407,962 16.9%
21 Levaquin Janssen Pharmaceuticals, Inc 1,355,350 -0.6%
22 (2) Celebrex Pfizer Inc 1,349,833 -6.9%
23 (2) Diovan HCT Novartis Corporation 1,314,507 3.7%
24 (4) Januvia Merck & Co., Inc. 1,294,408 13.0%
25 (16) Suboxone Reckitt Benckiser Pharmaceuticals Inc. 1,164,872 26.6%
26 (14) NovoLog Novo Nordisk, Inc. 1,101,447 20.6%
27 (9) Viagra Pfizer Inc 1,028,769 5.5%
28 (4) Atripla Gilead Sciences, Inc. 1,028,753 -6.5%
29 (3) Tricor Abbott Laboratories 1,015,682 -17.2%
30 (13) Provigil Cephalon, Inc. (a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd) 999,975 6.7%
31 (2) Zetia Merck & Co., Inc. 985,823 -4.3%
32 (12) Geodon oral Pfizer Inc 959,057 8.7%
33 (4) Vytorin Merck & Co., Inc. 953,625 -16.3%
34 (1) Ambien CR Sanofi (formerly Sanofi Aventis) 951,108 -2.5%
35 (11) Lunesta Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) 948,621 17.6%
36 (2) Lidoderm Endo Pharmaceuticals 934,418 -1.1%
37 (22) Lantus SoloSTAR Sanofi (formerly Sanofi Aventis) 933,589 50.5%
38 (15) Vyvanse Shire US Inc 931,421 40.9%
39 (5) Aciphex Eisai Corporation 915,796 -8.8%
40 (2) Nasonex Merck & Co., Inc. 886,446 -1.9%
41 (10) Lovenox Sanofi (formerly Sanofi Aventis) 867,240 -20.4%
42 (12) Adderall XR Shire US Inc 837,448 -27.0%
43 (4) ProAir HFA Teva Pharmaceuticals 818,903 -12.6%
44 (1) Truvada Gilead Sciences, Inc. 813,944 -8.5%
45 (3) Niaspan Abbott Laboratories 793,882 11.0%
46 (1) Humalog Eli Lilly and Company 783,294 3.2%
47 (8) Cialis Eli Lilly and Company 756,576 15.9%
48 (4) Namenda Forest Pharmaceuticals, Inc 744,296 10.9%
49 (27) Symbicort AstraZeneca Pharmaceuticals, LP 707,468 47.4%
50 (8) Flovent HFA GlaxoSmithKline 704,631 13.2%
51 (52) Seroquel XR AstraZeneca Pharmaceuticals, LP 695,560 92.1%
52 (8) Combivent Boehringer Ingelheim Pharmaceuticals, Inc 693,068 14.3%
53 () Lovaza GlaxoSmithKline 682,384 15.5%
54 (24) Solodyn Medicis Pharmaceutical Corporation 673,427 40.7%
55 (6) Detrol LA Pfizer Inc 620,231 -13.6%
56 (8) AndroGel Abbott Laboratories 593,780 10.1%
57 (10) Benicar Daiichi Sankyo 567,636 10.0%
58 (38) Levemir Novo Nordisk, Inc. 567,341 41.1%
59 (2) Enbrel Amgen Inc. 546,814 -15.8%
60 (44) Valtrex GlaxoSmithKline 533,961 -69.9%
61 (2) Benicar HCT Daiichi Sankyo 526,177 -3.1%
62 (7) Gleevec Novartis Corporation 517,967 -3.7%
63 (14) Humira Pen Abbott Laboratories 514,735 10.1%
64 (10) Synthroid Abbott Laboratories 506,859 2.5%
65 (20) Xalatan Pfizer Inc 502,227 9.1%
66 (2) Premarin tabs Wyeth 497,757 -6.5%
67 (5) Strattera Eli Lilly and Company 496,960 -3.9%
68 (46) Ventolin HFA GlaxoSmithKline 496,659 65.4%
69 (52) Flomax Boehringer Ingelheim Pharmaceuticals, Inc 486,106 -68.9%
70 (52) Loestrin 24 Fe Teva Pharmaceuticals 483,754 82.3%
71 (13) Protonix Wyeth 481,429 3.5%
72 (1) Boniva Genentech, Inc (member of Roche group) 480,470 -5.3%
73 (22) Restasis Allergan, Inc 480,414 19.0%
74 (14) Femara Novartis Corporation 477,256 12.7%
75 (18) Enbrel Sureclick Amgen Inc. 474,602 2.6%
76 (17) NovoLog Mix 70/30 Novo Nordisk, Inc. 470,786 16.8%
77 (6) Evista Eli Lilly and Company 469,013 0.3%
78 (16) Byetta Amylin Pharmaceuticals, Inc. 459,454 -17.8%
79 (20) Janumet Merck & Co., Inc. 459,068 22.7%
80 (5) Asacol Procter & Gamble 450,645 -8.3%
81 (9) Avodart GlaxoSmithKline 441,486 5.5%
82 (16) Vesicare Astellas Pharma US 440,862 15.3%
83 (68) Trilipix Abbott Laboratories 428,978 104.5%
84 (3) Copaxone Sanofi (formerly Sanofi Aventis) 421,758 1.3%
85 (19) Focalin XR Novartis Corporation 416,245 18.6%
86 (16) Reyataz Bristol-Myers Squibb Company 412,293 -20.9%
87 (37) Pristiq Wyeth 411,715 58.4%
88 (32) Arimidex AstraZeneca Pharmaceuticals, LP 403,891 -37.5%
89 (9) Chantix Pfizer Inc 394,944 -14.3%
90 (10) Sensipar Amgen Inc. 382,232 -0.5%
91 (3) Avapro Bristol-Myers Squibb Company 369,596 -6.2%
92 (49) Opana ER Endo Pharmaceuticals 366,417 52.5%
93 (43) Yaz Bayer Healthcare Pharmaceuticals 361,958 -49.1%
94 (27) Doryx Pfizer Inc 361,662 35.7%
95 (13) Actoplus Met Takeda Pharmaceuticals U.S.A., Inc 359,790 4.7%
96 (19) Humira Abbott Laboratories 358,012 -12.5%
97 Avelox Bayer Healthcare Pharmaceuticals 353,130 -8.4%
98 (13) NuvaRing Merck & Co., Inc. 349,014 11.0%
99 () Renvela Genzyme Corporation 333,987 111.5%
100 (35) Ortho Tri-Cyclen Lo Ortho-McNeil-Janssen Pharmaceuticals, Inc. 331,730 33.9%
101 (28) Lamictal GlaxoSmithKline 326,331 -35.2%
102 (4) Avalide Bristol-Myers Squibb Company 324,571 -6.4%
103 (1) Xopenex Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) 316,162 -13.0%
104 (18) Actonel Actavis (acquired Watson & Warner Chilcott) 313,904 -29.0%
105 () Dexilant/Kapidex 313,386 254.8%
106 (4) Lotrel Novartis Corporation 306,010 -6.8%
107 (9) Invega Janssen Pharmaceuticals, Inc 304,182 5.1%
108 (24) Welchol Daiichi Sankyo 303,392 19.7%
109 (11) Avonex Biogen Idec 303,147 0.2%
110 (73) Topamax Janssen Pharmaceuticals, Inc 287,186 -70.5%
111 (1) Norvir Abbott Laboratories 287,102 -10.0%
112 (46) Entocort EC AstraZeneca Pharmaceuticals, LP 282,547 38.6%
113 (15) Aggrenox Boehringer Ingelheim Pharmaceuticals, Inc 277,144 6.5%
114 (51) Travatan Z Alcon Laboratories, Inc. 273,598 44.1%
115 Isentress Merck & Co., Inc. 272,132 -9.8%
116 (25) Avandia GlaxoSmithKline 269,213 -33.8%
117 Prevacid SoluTab Takeda Pharmaceuticals U.S.A., Inc 268,284 -1.4%
118 (27) Exforge Novartis Corporation 267,771 16.6%
119 (68) Cozaar Merck & Co., Inc. 267,081 -62.4%
120 (9) Lumigan Allergan, Inc 267,047 7.0%
121 (12) Caduet Pfizer Inc 266,967 -18.6%
122 (36) Actonel 150 Actavis (acquired Watson & Warner Chilcott) 264,858 26.2%
123 (5) Risperdal Consta Janssen Pharmaceuticals, Inc 262,054 -8.2%
124 (59) Prograf Astellas Pharma US 260,885 -56.2%
125 (27) Ciprodex otic Alcon Laboratories, Inc. 254,888 13.8%
126 (23) Vigamox Alcon Laboratories, Inc. 252,864 11.3%
127 (7) Kadian Actavis (acquired Watson & Warner Chilcott) 251,858 -0.8%
128 (2) Coreg CR GlaxoSmithKline 251,440 -1.6%
129 (4) Levitra Bayer Healthcare Pharmaceuticals 242,446 -5.9%
130 (8) Maxalt Merck & Co., Inc. 242,237 0.5%
131 (24) Keppra UCB Inc. 241,737 -33.0%
132 (122) Prevacid Takeda Pharmaceuticals U.S.A., Inc 241,374 -90.6%
133 (27) Micardis Boehringer Ingelheim Pharmaceuticals, Inc 238,335 23.9%
134 () Bystolic Forest Pharmaceuticals, Inc 231,449 72.2%
135 (28) Prezista Centocor Ortho Biotech, Inc 230,406 13.8%
136 (52) Exelon Patch Novartis Corporation 229,601 38.2%
137 () Nuvigil Cephalon, Inc. (a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd) 223,885 239.6%
138 (2) Zyvox Pfizer Inc 222,554 -7.5%
139 (41) Lialda Shire US Inc 222,201 29.3%
140 (15) Epzicom GlaxoSmithKline 221,406 -17.0%
141 (20) Enablex Warner Chilcott 220,478 11.0%
142 (19) Forteo Eli Lilly and Company 219,387 -25.1%
143 (7) Viread Gilead Sciences, Inc. 216,264 -6.2%
144 (31) Kaletra Abbott Laboratories 212,723 -32.9%
145 (17) Micardis HCT Abbott Laboratories 211,575 10.4%
146 (8) Maxalt MLT Merck & Co., Inc. 211,230 -1.1%
147 Humalog Mix 75/25 Pen Eli Lilly and Company 211,021 -6.9%
148 (12) Xeloda Genentech, Inc (member of Roche group) 209,499 -11.7%
149 (7) Asmanex Merck & Co., Inc. 208,839 3.8%
150 (84) Hyzaar Merck & Co., Inc. 207,471 -62.3%
151 (20) Fentora Cephalon, Inc. (a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd) 207,376 11.2%
152 (91) Pulmicort Respules AstraZeneca Pharmaceuticals, LP 205,218 -68.0%
153 () Ranexa Gilead Sciences, Inc. 200,622 41.5%
154 (49) RenaGel Genzyme Corporation 199,275 -48.2%
155 (34) Prempro Pfizer Inc 198,132 22.2%
156 (1) Relpax Pfizer Inc 197,341 -3.4%
157 (12) Patanol Alcon Laboratories, Inc. 196,500 2.6%
158 (8) Amitiza Takeda Pharmaceuticals U.S.A., Inc 195,132 1.4%
159 (4) Duragesic Johnson & Johnson 194,599 -14.5%
160 () Vancocin HCl Eli Lilly and Company 192,066 23.4%
161 (22) Nasacort AQ Sanofi (formerly Sanofi Aventis) 192,035 -19.0%
162 (35) Proventil HFA Merck & Co., Inc. 191,839 -26.5%
163 () Advair HFA GlaxoSmithKline 191,245 26.4%
164 (14) Valcyte Roche Pharmaceuticals 191,160 -0.9%
165 (21) Wellbutrin XL Valeant Pharmaceuticals International 189,026 -21.2%
166 () Oracea Galderma Laboratories 187,182 67.9%
167 (18) Vivelle-DOT Novartis Corporation 185,860 12.4%
168 (11) Uroxatral 185,624 6.2%
169 (8) Zovirax topical GlaxoSmithKline 184,377 2.6%
170 (27) Epipen 182,785 20.8%
171 () Creon Abbott Laboratories 181,303 358.6%
172 () Azor Daiichi Sankyo 179,647 33.0%
173 (9) Pentasa Sanofi (formerly Sanofi Aventis) 178,068 4.5%
174 (32) Procrit Centocor Ortho Biotech, Inc 174,622 -25.9%
175 () Pataday Alcon Laboratories, Inc. 173,553 25.5%
176 (30) Differin Galderma Laboratories 171,454 -24.8%
177 (10) Premarin vaginal Pfizer Inc 170,860 3.5%
178 () Zyprexa Zydis Eli Lilly and Company 169,714 6.7%
179 (36) Tussionex Sanofi (formerly Sanofi Aventis) 169,611 -29.8%
180 () Victoza Novo Nordisk, Inc. 168,943 0.0%
181 () Humalog KwikPen Eli Lilly and Company 168,270 79.6%
182 () Arixtra GlaxoSmithKline 165,530 19.9%
183 () Qvar Janssen Pharmaceuticals, Inc 163,697 41.1%
184 (36) Combivir GlaxoSmithKline 163,406 -27.8%
185 () Testim 163,015 12.2%
186 (60) Tarceva Astellas Pharma US 160,591 -38.2%
187 (17) Xyzal Sanofi (formerly Sanofi Aventis) 160,237 -15.6%
188 (12) Elmiron Ortho-McNeil-Janssen Pharmaceuticals, Inc. 158,274 4.3%
189 (5) Propecia Merck & Co., Inc. 157,892 -5.7%
190 (108) CellCept Roche Pharmaceuticals 157,743 -68.3%
191 (110) Skelaxin Elan Corporation 156,372 -67.7%
192 () Betaseron Bayer Healthcare Pharmaceuticals 155,952 -6.8%
193 (12) Temodar Merck & Co., Inc. 154,466 -14.9%
194 () Flector Actavis (acquired Watson & Warner Chilcott) 153,814 0.2%
195 (27) Pegasys Genentech, Inc (member of Roche group) 153,101 -8.4%
196 (6) Prandin Novo Nordisk, Inc. 151,678 -5.9%
197 (5) Veramyst GlaxoSmithKline 150,582 -7.8%
198 () Intuniv Shire US Inc 150,346 NA
199 () Clobex Galderma Laboratories 150,230 20.6%
200 () Humulin N Eli Lilly and Company 149,945 4.4%

Source: Verispan, VONA

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Hide
(web2)